Changes

Jump to navigation Jump to search
438 bytes added ,  13:21, 6 March 2023
no edit summary
Line 1: Line 1:  +
{{CiteButton}}
 
{{#seo:
 
{{#seo:
 
|title=Cardiac diseases  
 
|title=Cardiac diseases  
Line 31: Line 32:  
|data6 = carakasamhita@gmail.com
 
|data6 = carakasamhita@gmail.com
   −
|label7 = Date of first publication:
+
|label7 = Publisher
|data7 = June 26, 2021
+
|data7 = [[Charak Samhita Research, Training and Development Centre]], I.T.R.A., Jamnagar, India
   −
|label8 = DOI
+
|label8 = Date of first publication:
|data8 = Under process
+
|data8 = June 26, 2021
 +
 
 +
|label9 = DOI
 +
|data9 = 10.47468/CSNE.2021.e01.s09.062
 
}}
 
}}
   
'''Updates on management of cardiac diseases through Ayurveda'''
 
'''Updates on management of cardiac diseases through Ayurveda'''
 
+
<p style='text-align:justify;'>
(This article is based on lecture delivered by Dr. Rohit Sane in Prof.M.S.Baghel Memorial Lecture Series on June 09, 2021.)
+
This article is based on lecture delivered by Dr. Rohit Sane in Prof.M.S.Baghel Memorial Lecture Series on June 09, 2021. The video lecture can be accessed on the link of [https://fb.watch/8l7PEmmWxC/ facebook page.]
<div style='text-align:justify;'>
+
<br/>
 
   
The major chronic diseases prevailing in India are cardiovascular disorders (CVD), diabetes, hypertension, obesity and dyslipidemia. Mortality due to cardiovascular disease is increasing substantially. In the year 1990, the mortality rate due to CVD  in India was 15.2, which increased to 28.1 in 2016.<ref>India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016.Lancet Glob Health 2018; 6: e1339–51 Available from https://www.thelancet.com/action/showPdf?pii=S2214-109X%2818%2930407-8 cited on 23/06/2021 </ref>  Despite the advancements in modern medicine, especially in treating CVD like angioplasty, bypass surgery, etc., the disease burden is increasing. [[Ayurveda]] can play a significant role in treating CVD as a lifestyle disorder and a non-communicable disorder.
 
The major chronic diseases prevailing in India are cardiovascular disorders (CVD), diabetes, hypertension, obesity and dyslipidemia. Mortality due to cardiovascular disease is increasing substantially. In the year 1990, the mortality rate due to CVD  in India was 15.2, which increased to 28.1 in 2016.<ref>India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016.Lancet Glob Health 2018; 6: e1339–51 Available from https://www.thelancet.com/action/showPdf?pii=S2214-109X%2818%2930407-8 cited on 23/06/2021 </ref>  Despite the advancements in modern medicine, especially in treating CVD like angioplasty, bypass surgery, etc., the disease burden is increasing. [[Ayurveda]] can play a significant role in treating CVD as a lifestyle disorder and a non-communicable disorder.
 
+
<br/>
The risk factors of CVD are diabetes, hypertension, and obesity. The burden of these lifestyle disorders is also high on the rise.  As per the data available, 9.7% of the adult population in India has Diabetes.<ref>Akhtar SN, Dhillon P. Prevalence of diagnosed diabetes and associated risk factors: Evidence from the large-scale surveys in India. J Soc Health Diabetes [serial online] 2017 [cited 2017 Oct 15 ];5:28-36</ref>  Hypertension is present in 25% of urban and 10% of rural subjects in India. Stage I hypertension carries significant cardiovascular risk.<ref>Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004 Feb;18(2):73-8. doi: 10.1038/sj.jhh.1001633. PMID: 14730320.</ref> Therefore, it is essential to treat these comorbid conditions while treating CVD.
+
The risk factors of CVD are diabetes, hypertension, and obesity. The burden of these lifestyle disorders is also high on the rise.  As per the data available, 9.7% of the adult population in India has Diabetes.<ref>Akhtar SN, Dhillon P. Prevalence of diagnosed diabetes and associated risk factors: Evidence from the large-scale surveys in India. J Soc Health Diabetes [serial online] 2017 [cited 2017 Oct 15 ];5:28-36</ref>  Hypertension is present in 25% of urban and 10% of rural subjects in India. Stage I hypertension carries significant cardiovascular risk.<ref>Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004 Feb;18(2):73-8. doi: 10.1038/sj.jhh.1001633. PMID: 14730320.</ref> Therefore, it is essential to treat these comorbid conditions while treating CVD. </p>
    
==Importance of animal trials==
 
==Importance of animal trials==
Line 78: Line 80:  
Since Bramhi and Shunthi are calcium channel antagonists they can be used for patients with systolic hypertension. Vacha, Bibhitaki and Pippali can be used in diastolic hypertension as they are ACE inhibitors. Kalaajaji and Punarnava are excellent diuretics to be used very effectively in the early phase of hypertension.
 
Since Bramhi and Shunthi are calcium channel antagonists they can be used for patients with systolic hypertension. Vacha, Bibhitaki and Pippali can be used in diastolic hypertension as they are ACE inhibitors. Kalaajaji and Punarnava are excellent diuretics to be used very effectively in the early phase of hypertension.
   −
==Anti-diabeti cherbs==
+
==Anti-diabetic herbs==
    
Some of the Ayurvedic herbs used in diabetes management and their mechanism of action are shown in Table 2.  
 
Some of the Ayurvedic herbs used in diabetes management and their mechanism of action are shown in Table 2.  
Line 99: Line 101:  
|}
 
|}
   −
*Gudmar also has the capacity to produce a coat over the intestine so that the carbohydrate absorption through the gut gets reduced.
+
*Gudmar also has the capacity to produce a coat over the intestine so that the carbohydrate absorption through the gut gets reduced.
    
==Herbs for management of coronary artery disease==
 
==Herbs for management of coronary artery disease==
Line 110: Line 112:  
! Herb  !! Latin Name !! Mechanism of action
 
! Herb  !! Latin Name !! Mechanism of action
 
|-
 
|-
! Vrikshamla !! Garcinia indica !! Anti inflammatory, Hypolipidemic
+
! '''Vrikshamla''' !! '''Garcinia indica''' !! Anti inflammatory, Hypolipidemic
 
|-
 
|-
 
! Matulunga !! Citrus medica !! Anti inflammatory, Hypolipidemic
 
! Matulunga !! Citrus medica !! Anti inflammatory, Hypolipidemic
Line 157: Line 159:     
====Efficacy in ischemic heart disease====  
 
====Efficacy in ischemic heart disease====  
[[File:Image 3.JPG|500px|'''Image 3: Ischemia Reduction on Myocardial Perfusionthrough SPECT MPI'''|thumb]]
+
[[File:Image 3.JPG|400x400px|'''Image 3: Ischemia Reduction on Myocardial Perfusion through SPECT MPI'''|thumb|alt=]]
    
Stress Thallium test was applied to assess the reversal of ischemic changes in patients of CHF associated with myocardial ischemia. The radioactive isotope Thallium was injected into the bloodstream of cardiac patients. Gamma scanner was used to assess the circulation of thallium in the myocardium. After three months of ischemia reversal program, 30.33% of the reduction was observed in ischemia on Myocardial Perfusion
 
Stress Thallium test was applied to assess the reversal of ischemic changes in patients of CHF associated with myocardial ischemia. The radioactive isotope Thallium was injected into the bloodstream of cardiac patients. Gamma scanner was used to assess the circulation of thallium in the myocardium. After three months of ischemia reversal program, 30.33% of the reduction was observed in ischemia on Myocardial Perfusion
through SPECT MPI.<ref>Rohit S, Jagdish H, Chandrakant C, Sujit N, Rahul M (2020) Ischemia Reversal Therapy as an add-on Therapy for Ischemic Heart Disease: A Pilot Study based on SPECT Myocardial Perfusion Imaging. J Cardiovasc Dis Diagn 8: 397.</ref>
+
through SPECT MPI.<ref>Sane R., Jagdish H, Chandrakant C, Sujit N, Rahul M (2020) Ischemia Reversal Therapy as an add-on Therapy for Ischemic Heart Disease: A Pilot Study based on SPECT Myocardial Perfusion Imaging. J Cardiovasc Dis Diagn 8: 397.</ref>
    
====Effect on left ventricular distress====
 
====Effect on left ventricular distress====
Line 187: Line 189:  
'''Ans''': [[Prakriti]] and the involvement of [[dosha]] are very much influencing the development of cardiac disorders. Typical presentations explained for different kinds of hridroga (cardiac disorders) can be seen in patients. For eg. In vataja hridroga the pain will be severe. It may be cutting, stabbing, tearing etc., in nature. In kaphaja hridrog pain will be minimal. The other symptoms like excessive salivation, heaviness in the chest etc., are more predominant. In pittaja hridroga burning in the sternum/epigastric region is the main presenting feature. The classical treatments mentioned for these individual types of cardiac disorders give an excellent result.
 
'''Ans''': [[Prakriti]] and the involvement of [[dosha]] are very much influencing the development of cardiac disorders. Typical presentations explained for different kinds of hridroga (cardiac disorders) can be seen in patients. For eg. In vataja hridroga the pain will be severe. It may be cutting, stabbing, tearing etc., in nature. In kaphaja hridrog pain will be minimal. The other symptoms like excessive salivation, heaviness in the chest etc., are more predominant. In pittaja hridroga burning in the sternum/epigastric region is the main presenting feature. The classical treatments mentioned for these individual types of cardiac disorders give an excellent result.
 
</div>
 
</div>
   
+
 
 +
<big>'''Link to video lecture: https://fb.watch/8l7PEmmWxC/'''</big>
 +
 
 +
<big>'''[[Special:ContactMe|Send us your suggestions and feedback on this page.]]'''</big>
 +
 
 
==References==
 
==References==
  

Navigation menu